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The CD28 Signaling Pathway
Regulates Glucose Metabolism
of metabolism in response to changes in cellular condi-
tions. However, it has recently been shown that signals
from cell surface receptors are required to control the
Kenneth A. Frauwirth,1,2,5 James L. Riley,1,3,5
Marian H. Harris,1,2 Richard V. Parry,1,3
Jeffrey C. Rathmell,1,2 David R. Plas,1,2
Rebecca L. Elstrom,1 Carl H. June,1,3 ability of resting cells to take up and utilize nutrients
at levels sufficient to maintain viability (Rathmell et al.,and Craig B. Thompson1,2,4
1Abramson Family Cancer Research Institute 2000). Further, in fat and muscle cells insulin induces
glucose uptake in excess of that required to maintain2 Department of Cancer Biology
3 Department of Pathology and Laboratory Medicine cellular energy charge, allowing the synthesis of triglyc-
erides and glycogen for storage. In T cells, the costimu-University of Pennsylvania
Philadelphia, Pennsylvania 19104 latory receptor CD28 participates in an intracellular sig-
naling pathway, some of whose proximal components
are similar to those in the insulin receptor pathway. The
binding of insulin to the insulin receptor results in theSummary
activation of intrinsic tyrosine kinase activity and leads
to recruitment and phosphorylation of insulin receptorLymphocyte activation initiates a program of cell
growth, proliferation, and differentiation that increases substrate-1 (IRS-1). Phosphorylated IRS-1, in turn, re-
cruits and activates PI3K (Lee and Pilch, 1994). Similarly,metabolic demand. Although T cells increase glucose
uptake and glycolysis during an immune response, upon ligation of the T cell receptor (TCR), activation of
Lck or Fyn in the TCR/CD3 complex leads to the tyrosinethe signaling pathways that regulate these increases
remain largely unknown. Here we show that CD28 phosphorylation of the cytoplasmic tail of CD28, which
then acts as an adaptor for the recruitment and activa-costimulation, acting through phosphatidylinositol
3-kinase (PI3K) and Akt, is required for T cells to in- tion of PI3K (August and Dupont, 1994; Chuang et al.,
1999; Pages et al., 1994; Prasad et al., 1994; Truitt etcrease their glycolytic rate in response to activation.
Furthermore, CD28 controls a primary response path- al., 1994).
The similarity in signaling pathways downstream ofway, inducing a level of glucose uptake and glycolysis
in excess of that needed to maintain cellular ATP/ the insulin receptor and CD28 suggest that CD28 may
act to regulate glucose utilization, coordinating the con-ADP levels or macromolecular synthesis. These data
suggest that CD28 costimulation functions to increase trol of T cell activation and metabolism in a manner
similar to that of the insulin receptor. Here we show thatglycolytic flux, allowing T cells to anticipate energetic
and biosynthetic needs associated with a sustained CD28 costimulation of human peripheral blood T cells
enhances expression of glucose transporters, glucoseresponse.
uptake, and glycolysis, and that this enhancement is
dependent on PI3K activity. Further, the majority of glu-Introduction
cose processed by CD28-costimulated T cells is con-
verted to lactate and secreted, rather than used for bio-During the activation of a resting lymphocyte, large met-
abolic demands are placed on the cell as it initiates synthesis or oxidized for maximal energy extraction.
These data indicate that the increased metabolism isproliferation and cytokine production (Krauss et al.,
2001). The cell grows to approximately double its resting not a homeostatic response to increased demands but
is a result of a primary signal transduction pathway fromsize and then enters a program of rapid proliferation
while also differentiating from a quiescent cell to one CD28.
that is highly secretory. Reflecting these increased en-
ergy demands, activation of T cells by mitogenic lectins Results
such as concanavalin A, phytohaemagglutinin, and
pokeweed mitogen is associated with increases in gly- The primary downstream mediator of the metabolic ef-
colysis (Cooper et al., 1963; Culvenor and Weidemann, fects of insulin is the Ser/Thr kinase Akt (Summers et
1976; Hedeskov, 1968; Roos and Loos, 1970; Sagone al., 1999). CD28 costimulation of human peripheral blood
et al., 1974). Unlike hepatocytes and myocytes, two cell T cells induces a prolonged activation of Akt that is PI3K
types in which metabolic pathways have been well stud- dependent. Stimulation of resting human peripheral
ied, resting lymphocytes do not have large internal gly- blood T cells with magnetic beads coated with anti-
cogen stores, making them highly dependent on the CD3/anti-CD28 antibodies but not with anti-CD3 alone
import of extracellular glucose to meet increased meta- led to Akt activation within 5 min (Figure 1A). This activa-
bolic needs. tion peaked within 30 min but was still detectable 3 hr
Many studies suggest that glucose uptake and glyco- after stimulation (see Figure 3A) and was blocked by
lytic regulation is homeostatically controlled by cellular the PI3K inhibitor LY294002 (Figure 1A). Although some
ATP and metabolite levels. In this model, a primary sig- activation of Akt by anti-CD3 alone was detected, costi-
naling pathway is not required to allow the modulation mulation by CD28 was required for sustained activation.
These data support a model in which the TCR and
CD28 synergize to activate Akt (Figure 1B). In the insulin4 Correspondence: drt@mail.med.upenn.edu
5 These authors contributed equally to this work. signaling pathway, Akt activation stimulates the synthe-
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Figure 1. CD28 Costimulation Induces Sus-
tained PI3K-Dependent Akt Activation and In-
creased Expression of Glut1
(A) CD28 costimulation activates Akt in hu-
man peripheral blood T cells in a PI3K-depen-
dent fashion. Purified T cells were cultured in
the absence of antibodies (resting) or stimu-
lated with anti-CD3 (CD3) or anti-CD3/anti-
CD28 (CD3/CD28) antibodies for the indi-
cated times. Akt activation was detected by
Western blot for Ser473-phosphorylated Akt
(top panels, p-Akt). The blot was then stripped
and reprobed for total Akt (bottom panels, Akt).
PI3K dependence was determined by stimula-
tion in the presence of 10 M LY294002 (CD3/
CD28/LY).
(B) Pathway for Akt activation in T cells.
(C) CD28 costimulation induces Glut1. T cells
were stimulated for 20 hr with the indicated
antibodies, and total cellular Glut1 was mea-
sured flow cytometrically. Anti-MHC antibody
was used as a nonstimulatory control (control
Ab). Cells were also stained in the absence
of primary anti-Glut1 antibody (No 1 Ab) as
a specificity control.
(D) Glut1 induction is PI3K dependent. T cells
were stimulated with control, anti-CD3, or
anti-CD3/anti-CD28 Abs in the absence or
presence of 1 M or 10 M LY294002, and
Glut1 levels were measured as in (C). Higher
doses of LY294002 could induce further sup-
pression of Glut1 induction but also appear
to be associated with nonspecific toxicity (not
shown). Data are representative of three inde-
pendent experiments.
sis and surface expression of glucose transporters and (Williamson et al., 1993). Furthermore, activation of Akt
by CD28 has been suggested to function primarily toregulates glucose utilization (Barthel et al., 1999; Cong
et al., 1997; Kohn et al., 1996; Taha et al., 1999; Ueki et upregulate IL-2 expression. (Kane et al., 2001; Parry
et al., 1997). To determine if the Glut1 induction wasal., 1998; Wang et al., 1999). We therefore tested the
ability of CD28 to regulate glucose metabolism during secondary to IL-2 signaling, we tested the effects of
supplementing anti-CD3 cultures with recombinant IL-2.human T cell activation. The first point of regulation of
glucose utilization by a cell is the control of uptake via At levels comparable to those seen in anti-CD3/anti-
CD28 cultures, IL-2 was unable to mimic the effects ofsurface glucose transporters. Resting T cells express
low levels of Glut1, the primary glucose transporter of CD28 costimulation on Glut1 levels (Figure 2A). To fur-
ther test the role of IL-2, we also cultured T cells in thehematopoietic cells (Rathmell et al., 2000). Neither acti-
vation by crosslinking the TCR/CD3 complex nor ligation presence or absence of neutralizing anti-IL-2 antibody
during stimulation with anti-CD3/anti-CD28-coatedof CD28 alone resulted in a significant change in Glut1
expression. In contrast, stimulation with anti-CD3/anti- beads. Addition of the blocking anti-IL-2 antibody re-
duced levels of functional IL-2 in anti-CD3/anti-CD28CD28 led to a synergistic induction of Glut1 expression
(Figure 1C) that was sensitive to inhibition by LY294002 culture supernatants by90% (data not shown) but did
not result in a decrease in Glut1 expression (Figure 2A).in a dose-dependent fashion (Figure 1D). Thus, CD28
costimulation is required to increase glucose trans- Although IL-2 was not sufficient to replace CD28 sig-
naling in the induction of Glut1, CD28 can augment theporter expression during T cell activation, and this is
dependent on the ability of CD28 to induce PI3K acti- expression of other cytokines in addition to IL-2. To
rule out other secreted cytokines as mediators of Glut1vation.
Increased synthesis and secretion of interleukin-2 (IL-2) upregulation, we also stimulated T cells with anti-CD3
in conditioned medium harvested from anti-CD3/anti-and other cytokines are also hallmarks of T cell activa-
tion in the presence of costimulation, and binding of CD28-stimulated cells. Unlike direct stimulation with
anti-CD3/anti-CD28, addition of anti-CD3/anti-CD28-IL-2 to the IL-2 receptor on T cells can activate PI3K
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Figure 2. Increased Glut1 Expression after
CD28 Costimulation Is Not Mediated by Se-
creted Cytokines
T cells were stimulated as in Figure 1. Anti-
CD3-stimulated cells were cultured with anti-
CD3 alone (CD3) ([A] and [B]), anti-CD3 with
300 U/ml IL-2 (CD3  IL-2) (A), or anti-CD3
with conditioned medium from anti-CD3/anti-
CD28-stimulated cultures (CD3  cond. med.)
(B). Anti-CD3/anti-CD28-stimulated cells were
cultured without (CD3/CD28) ([A] and [B]) or
with 1 g/ml anti-IL-2 Ab (CD3/CD28  anti-
IL-2) (A). Glut1 levels were determined by flow
cytometry as in Figure 1.
conditioned medium failed to enhance Glut1 expression secreted. This represents a significant decrease in the
efficiency of glucose utilization by CD28-costimulatedduring anti-CD3 stimulation (Figure 2B).
In order to examine the significance of the increased T cells to support either ATP production or macromolec-
ular synthesis.Glut1 expression in CD28-costimulated cells, we mea-
sured glucose uptake rates in cells stimulated as de- One concern in considering the ability of CD28 to
upregulate glucose metabolism is that this upregulationscribed above. Anti-CD3/anti-CD28 significantly in-
creased glucose uptake, while either antibody alone had could be due to the established ability of CD28 costimu-
lation to induce T cell proliferation at low levels of TCRno effect on the uptake rate (Figure 3A). As with Glut1
expression, the increase in glucose uptake was not re- engagement. To address this issue, T cells were stimu-
lated with increasing amounts of anti-CD3. At mitogenicduced by anti-IL-2 antibody, and exogenous IL-2 was
unable to substitute for CD28 costimulation. Stimulation doses, anti-CD3 induced a small but consistent increase
in glycolysis when compared to unstimulated cells. Nev-with anti-CD3/anti-CD28 for as little as 6 hr was suffi-
cient to produce a significant increase in glucose ertheless, at all doses of anti-CD3 tested, the addition
of CD28 costimulation led to a 5-fold further increaseuptake.
We next investigated whether the enhanced glucose in glucose metabolism without inducing a comparable
increase in proliferation (Figure 4).uptake resulted in an increased glycolytic rate. Stimula-
tion with anti-CD3 alone had a minimal effect on glyco- The data above suggest that CD28 signal transduction
can increase glucose consumption beyond what islytic rate, as measured at the dehydration reaction cata-
lyzed by enolase, the penultimate step of glycolysis strictly required to maintain the bioenergetics of a prolif-
erating cell. The T cell appears to deal with this excess(Figure 3B). However, the anti-CD3 stimulation condi-
tions were sufficient to initiate signal transduction and in glucose consumption by secreting it as lactate. In-
creased production of lactate by mitogen-activated Tregulate the transcription of over 500 genes (Riley et
al., 2002). In contrast, CD28 costimulation dramatically cells and leukemic T cell lines has been reported (Cooper
et al., 1963; Culvenor and Weidemann, 1976; Hedeskov,increased the ability of T cells to perform glycolysis
(Figure 3B), an increase inhibitable by LY294002 (data 1968; Roos and Loos, 1970) and has been suggested
to indicate that lymphocytes have a limited ability tonot shown). Consistent with the Glut1 and glucose up-
take data, the CD28 enhancement of the glycolytic rate carry out oxidative phosphorylation. To address this is-
sue, T cells were cultured under conditions of limitedwas independent of IL-2 (Figure 3B) and not mimicked
by addition of anti-CD3/anti-CD28-conditioned medium extracellular glucose. T cells cultured in reduced glu-
cose (0.4 mM) had lower glycolytic rates than those(Figure 3C).
CD28 costimulation enhances T cell proliferation and cultured under standard glucose conditions (11 mM)
(Figure 5A). This represents a decrease in actual glyco-cytokine production. Therefore, the increases in glucose
uptake and glycolysis we observed could be secondary lytic capacity, as it was observed even when cells were
provided with 10 mM glucose in the assay buffer (datato a primary effect of CD28 costimulation on transcrip-
tion or translation. If glycolytic control during lympho- not shown). When glucose became limiting, the oxy-
gen:glucose consumption ratio for anti-CD3-stimulatedcyte activation is regulated homeostatically by ATP lev-
els and glycolytic intermediates, then the increase in cells rose from 2.5:1 in 11 mM glucose to over 6.0:1 in
0.4 mM glucose. These data indicate that there was aglucose utilization we observed could be a result of
the need to regenerate ATP and metabolites consumed shift to essentially complete oxidation of glucose, re-
sulting in maximal ATP generation from the limited glu-during macromolecular synthesis. However, we found
that the major product of the increased glucose metabo- cose supply (Figure 5B). Thus, anti-CD3-stimulated cells
in low glucose are unable to meet their bioenergeticlism stimulated by CD3/CD28 was lactate (Figure 3D).
As much as 90% of the glucose consumed by CD3/ needs through compensatory increases in glycolysis.
The ability to regulate oxidative phosphorylation in re-CD28-stimulated T cells was converted to lactate and
Immunity
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Figure 3. CD28 Costimulation Increases Glu-
cose Uptake, Glycolysis, and Lactate Pro-
duction
T cells were stimulated for 20 hr with the indi-
cated antibodies and uptake of [3 H]-2-deoxy-
glucose (A), glycolysis of 5-[3 H]-glucose ([B]
and [C]), and the increase in lactate in culture
medium ([D]; calculated as total lactate con-
centration minus the lactate concentration in
medium alone) were measured. Data are rep-
resentative of three independent experi-
ments. In (C), “CD3 cond. med.” represents
stimulation with anti-CD3 in the presence of
conditioned medium from anti-CD3/anti-CD28
cultures.
sponse to glucose deprivation was even more apparent the increases in glucose metabolism induced by CD28.
Crosslinking CTLA-4 with anti-CTLA-4 antibody blockedin anti-CD3/anti-CD28-stimulated cells. When glucose
levels were reduced in CD3/CD28-stimulated cultures, Akt activation by anti-CD3/anti-CD28 (Figure 6A), similar
to the effects of LY294002 (Figure 1A). Consistent withthere was a 4-fold increase in the absolute rate of oxygen
consumption, demonstrating that the cells had the ca- its blockade of Akt activity, anti-CTLA-4 inhibited the
induction of Glut1 expression (Figure 6B), glucose up-pacity to increase their rate of oxidative metabolism
under conditions of reduced extracellular glucose (Fig- take (Figure 6C), and glycolysis (Figure 6D) by anti-CD3/
anti-CD28. Thus, CTLA-4 blocks T cell activation in suchure 5B). This compensatory regulation of bioenergetics
is reflected in the ability of anti-CD3/anti-CD28-stimu- a manner as to prevent the upregulation of glucose
transport and glycolysis that results from CD28 costimu-lated T cells to survive and proliferate when cultured in
0.4 mM glucose (data not shown). Thus, the production lation.
The above data suggest that CD28 costimulation actsof lactate by costimulated T cells is not due to an inability
to increase their rate of oxidative phosphorylation, but to regulate nutrient uptake in lymphocytes through its
ability to act as an adaptor molecule in the activationreflects that glycolytic flux is occurring at a rate sufficient
to suppress ADP-coupled oxidative phosphorylation. of PI3K and, thus, Akt. To confirm that sustained activa-
tion of Akt is sufficient to account for the observedTogether, these data also suggest that activated T cells
lack homeostatic mechanisms to produce compensa- metabolic effects of CD28 costimulation, we used the
lymphoid cell line FL5.12 and transfected it with eithertory increases in glycolysis in response to glucose depri-
vation. constitutively active Akt1 or empty vector (Figure 7A).
In the presence of IL-3, Akt-transfected FL5.12 cellsCytotoxic T lymphocyte antigen-4 (CTLA-4) is a nega-
tive regulator of CD28 costimulation (Krummel and Alli- proliferated at a rate similar to control-transfected cells
(Figure 7B), indicating that net macromolecular synthe-son, 1995; Walunas et al., 1996). Although resting T cells
express very little surface CTLA-4, expression is in- sis of control and Akt transfectants was comparable.
However, Akt transfectants had a much higher rate ofduced within 1 hr of stimulation (Lindsten et al., 1993),
and inhibitory effects of CTLA-4 on IL-2 expression can glycolysis than control cells (Figure 7C). Consistent with
the increased glycolysis, Akt-transfected cells con-be detected within 4 hr (Blair et al., 1998; Brunner et al.,
1999). We therefore tested whether CTLA-4 can inhibit sumed glucose from the culture medium more rapidly
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mands of the cell. As the levels of intracellular ATP and/
or glycolytic intermediates drop, allosteric inhibition of
key glycolytic enzymes is relieved, resulting in an in-
crease in the rate of glycolysis. Conversely, negative
feedback prevents a cell from consuming nutrients be-
yond its short-term needs. We report that T cells receiv-
ing CD28 costimulation rapidly induce glucose uptake
and glycolysis to a level that is sufficient to suppress
oxidative phosphorylation. Furthermore, the rate at
which CD3/CD28-stimulated T cells process glucose is
in excess of that needed to sustain macromolecular
synthesis. The majority of the glucose taken up by the
cells is not incorporated into cellular macromolecules,
but instead is disposed of as lactate. The ability of CD28
to drive glucose metabolism beyond the level needed
for the immediate metabolic demands indicates that cell
surface signaling can result in a primary regulation of
glucose utilization. Such regulation would allow T cells
to anticipate the demands of activation, inducing syn-
thesis and activity of metabolic machinery before it be-
comes a bottleneck for T cell proliferation and function,
thus ensuring the availability of glycolytic intermediates
for biosynthetic and energetic reactions. This likely con-
tributes to the ability of CD28 costimulation to prolong
T cell viability and prevent the apoptotic death that char-
acteristically follows T cell stimulation via the TCR/CD3
complex alone.
Our results also bring into question whether T cells
have a homeostatic ability to increase either glucose
uptake or glycolysis in response to a decrease in the
ability to produce ATP. When glucose levels were low-
ered in the culture medium, anti-CD3-treated cells
switched to virtually complete oxidation of glucose
through oxidative phosphorylation but failed to maintain
glycolytic rate. However, the same concentration of glu-
cose was able support a 10-fold higher glycolysis rate
Figure 4. Mitogenic Doses of CD3 Do Not Augment Glycolysis to in anti-CD3/anti-CD28-stimulated cells. Thus, glucose
CD3/CD28 Levels levels were not limiting per se, but rather anti-CD3-stim-
T cells were stimulated with control Ab, anti-CD3, or anti-CD3/anti- ulated cells were unable to compensate by increasing
CD28, and glycolysis (A) and incorporation of [3 H]thymidine (B) were Glut1 expression and glucose transport capacity to
measured after 20 hr and 3 days, respectively. Error bars denote
maintain homeostasis in the face of reduced extracellu-standard deviation from the mean of triplicate measurements. Total
lar glucose concentration.amount of antibody bound to beads was kept constant; percentages
The identification of Akt as a potential signaling linkindicate the fraction of total antibody that is anti-CD3. In CD3 sam-
ples, the remainder is control antibody; in CD3/CD28 samples, the between CD28, CTLA-4, and T cell metabolism reveals
remainder is anti-CD28 Ab. For comparison, stimulations for Figures an interesting parallel with the insulin signaling pathway.
1–3 used 5% CD3. Ligation of the insulin receptor causes the phosphoryla-
tion of IRS-1, which can then recruit and activate PI3K
than vector transfectants (Figure 7D) and produced (Lee and Pilch, 1994). Membrane recruitment of Akt by
higher levels of lactate (Figure 7E). In fact, Akt transfec- PI3K-generated phospholipids allows Akt phosphoryla-
tants depleted their glucose to such an extent within 3 tion and activation, which has been shown to be cen-
days of culture that the cells began consuming lactate trally involved in insulin-mediated increases in glucose
(Figures 7D and 7E), which can be converted back to transport and synthesis of glucose transporters (Barthel
pyruvate by lactate dehydrogenase. Therefore, as with et al., 1999; Cong et al., 1997; Kohn et al., 1996; Taha
costimulated primary T cells the increase in lactate pro- et al., 1999; Ueki et al., 1998; Wang et al., 1999). Phos-
duction is unlikely to be due to an inability to carry phorylation of CD28 by TCR/CD3-associated Lck or Fyn
out oxidative phosphorylation, but rather is due to a initiates a similar set of events (August and Dupont,
glycolytic flux that is in excess of energy demand. Thus, 1994; Chuang et al., 1999; Prasad et al., 1994; Truitt et
increased Akt activity enhances glucose consumption al., 1994), resulting in increased glucose metabolism.
to a level above that needed to meet energetic and However, while IRS-1 is directly recruited to the insulin
biosynthetic demands. receptor upon binding of insulin, recruitment of CD28
to the TCR/CD3 complex is dependent on binding of
Discussion CD28 to its ligands B7-1 or B7-2, adding a further level
of control to the regulation of T cell metabolism.
Insulin signaling is negatively regulated by phospha-The regulation of glycolysis is generally portrayed as a
homeostatic response to the immediate metabolic de- tases, such as PTEN, which opposes the activity of PI3K
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Figure 5. CD28-Costimulated T Cells Can Increase Oxidative Phosphorylation When Glycolysis Is Restricted by Glucose Limitation
T cells were left unstimulated (unstim) or stimulated with anti-CD3 mAb (CD3) or anti-CD3/anti-CD28 mAb (CD3/CD28) in either standard (11
mM) or reduced (0.4 mM) glucose for 3 days, and rates of glycolysis (A) and oxygen consumption (B) were measured. Error bars denote
standard deviation from the mean of triplicate measurements. Data are representative of three independent experiments.
(Simpson and Parsons, 2001), and PP2A, which deacti- prevents sustained Akt activity and Glut-1 expression,
the ability to prevent an upregulation of T cell metabo-vates Akt (Millward et al., 1999). The parallels between
the insulin receptor and CD28 pathways raise the possi- lism may be an important component of the inhibitory
activity of CTLA-4.bility that CD28 signaling is similarly regulated. The in-
hibitory receptor CTLA-4 has been shown to associate A rapid and sustained increase in lymphocyte metabo-
lism is required to support the proliferation, differentia-with the phosphatases SHP-2 and PP2A (Chuang et al.,
2000; Lee et al., 1998; Marengere et al., 1996), and we tion, and effector function resulting from an immune
response. Our results implicate CD28 costimulation act-have found that CTLA-4 crosslinking inhibits the activa-
tion of Akt and the metabolic effects of CD28 costimula- ing through the PI3K/Akt pathway as an important com-
ponent in the regulation of glucose metabolism. TCRtion. While these studies do not identify how CTLA-4
Figure 6. CTLA-4 Inhibits CD28 Effects on
Metabolism
(A) CTLA-4 inhibits Akt activation. T cells were
cultured without stimulation (resting) or stim-
ulated with the indicated antibodies for 3 hr.
Akt activation was detected by Western blot
(top panel; p-Akt) as in Figure 1A, and the
blot was stripped and reprobed for total Akt
(bottom panel; Akt). In one sample, an optimal
dose of anti-CD3/anti-CD28 mAb was used
for maximal Akt activation (far right lane).
(B–D) CTLA-4 prevents CD28-mediated in-
creases in glucose metabolism. T cells were
stimulated with the indicated antibodies for
20 hr, and induction of Glut1 expression (B),
glucose uptake (C), and glycolysis (D) were
measured as above. Error bars denote stan-
dard deviation from the mean of triplicate
measurements. Results are representative of
three independent experiments.
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Figure 7. Constitutive Akt Activity Increases Glucose Metabolism
(A) FL5.12 cells stably transfected with either control (Ctrl) or Akt constructs were assayed for total Akt (top panel; Akt) by Western blot. Blots
were subsequently stripped and reprobed for Akt activation-specific phosphorylation (middle panel; p-Akt) and actin (bottom panel).
(B) Ctrl-FL5.12 and Akt-FL5.12 cells were cultured for the indicated times in the presence of IL-3 and cells were counted. Error bars denote
standard deviation from the mean of three independent experiments.
(C) Comparison of glycolysis rates of Ctrl-FL5.12 and Akt-FL5.12 cells. Error bars represent standard deviation from the mean of triplicate
measurements. (D and E) Glucose (D) and lactate (E) levels in culture medium were analyzed over time for Ctrl-FL5.12 and Akt-FL5.12 cells.
Error bars denote standard deviation from the mean of three independent experiments.
signal transduction alone has the capacity to activate CD28-mediated PI3K activation. The loss of PTEN from
lymphoid cell lines may reflect the importance of theAkt under some conditions (Jones et al., 2000; Lafont
et al., 2000) and a limited ability to stimulate glycolysis PI3K/Akt pathway in the regulation of lymphocyte
growth. Enhancing access to nutrients through in-(Figure 4). Enhancement of cellular bioenergetics has
been reported in TCR-activated cells to result from stim- creased levels of glucose transporters and activity of
the glycolytic pathway appears to be one important wayulation of oxidative phosphorylation (Krauss et al., 2001),
a property of TCR engagement confirmed by our studies in which costimulatory receptors can stimulate T cell
growth.(Figure 5). In contrast, CD28 costimulation leads to pro-
longed Akt activation and upregulation of glycolysis.
Experimental ProceduresAlthough cytokines also have the ability to induce Akt
activation in antigen-primed T cells (Kelly et al., 2002;
T Cell PurificationLafont et al., 2000; Scheel-Toellner et al., 2002), they
Human peripheral blood T cells were isolated by magnetic bead
have not been reported to activate Akt in resting cells. negative selection as previously described (June et al., 1987).
Thus, while cytokines could be important in maintaining
the metabolism of activated cells, they do not appear Cell Lines and Culture
capable of replacing CD28 in the activation of glycolysis FL5.12 cells (an IL-3-dependent cell line) were cultured as previously
described (Vander Heiden et al., 1997). Tet-inducible mAkt-FL5.12during the initial stages of T cell activation.
cells have been described (Plas et al., 2001). FL5.12 cells constitu-The role of PI3K in CD28 signaling has been controver-
tively expressing mAkt1 were generated by retroviral transductionsial. Although several groups have reported PI3K activity
with pBABE expression vectors (Kennedy et al., 1997), provided by
to be dispensable for CD28 costimulatory function Dr. Nissim Hay (University of Illinois, Chicago, IL), and used for some
(Crooks et al., 1995; Harada et al., 2001a; Okkenhaug experiments. Cells were counted on a Coulter Z2 particle counter
et al., 2001; Truitt et al., 1995), others have found that (Beckman Coulter, Miami, FL).
the PI3K pathway is a significant component of CD28
signaling, particularly early in a T cell response. (Burr et Antibodies, Bead Preparation, and Cell Stimulation
Anti-CD3 (OKT3), anti-CD28 (9.3), anti-CTLA-4 (ER5.3D6), and anti-al., 2001; Cai et al., 1995; Harada et al., 2001b; Pages
MHC class I (W6/32) mAbs were covalently attached to tosyl-acti-et al., 1994). Part of the confusion may come from the
vated Dynabeads (Dynal, Great Neck, NY) following the manufactur-use of PTEN-deficient cells, such as Jurkat (Shan et al.,
er’s instructions, as previously described (Blair et al., 1998). In order
2000), for studies of CD28 function. In the absence of to see effects of CTLA-4, a suboptimal dose of anti-CD3 antibody
PTEN, cell lines have constitutive activation of Akt and was used (Blair et al., 1998).
Beads were mixed with T cells at a 3:1 ratio of beads:cells. Wheretherefore increased rates of glycolysis, independent of
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indicated, 300 U/ml of IL-2 (Chiron Therapeutics, Emeryville, CA) or Barthel, A., Okino, S.T., Liao, J., Nakatani, K., Li, J., Whitlock, J.P.,
Jr., and Roth, R.A. (1999). Regulation of GLUT1 gene transcription by1 g/ml of polyclonal goat anti-human IL-2 Abs (R&D Systems,
Minneapolis, MN) was added to the cultures. In some experiments, the serine/threonine kinase Akt1. J. Biol. Chem. 274, 20281–20286.
cultures were supplemented with the PI3K inhibitor LY294002 (Cal- Blair, P.J., Riley, J.L., Levine, B.L., Lee, K.P., Craighead, N., Fran-
biochem, San Diego, CA) at 1–10M. IL-2 in the culture medium was comano, T., Perfetto, S.J., Gray, G.S., Carreno, B.M., and June, C.H.
measured by sandwich ELISA using reagents from R&D Systems. (1998). CTLA-4 ligation delivers a unique signal to resting human
CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L)
Western Blots induction. J. Immunol. 160, 12–15.
T cells were left unstimulated or stimulated with bead-linked anti- Brunner, M.C., Chambers, C.A., Chan, F.K., Hanke, J., Winoto, A.,
bodies for times ranging from 5 min to 3 hr. Cells were lysed in and Allison, J.P. (1999). CTLA-4-mediated inhibition of early events
buffer containing 1% NP-40, 150 mM NaCl, 50 mM Tris-Cl (pH 7.4), of T cell proliferation. J. Immunol. 162, 5813–5820.
5 mM EDTA, and 10 mM iodoacetamide and supplemented with
Burr, J.S., Savage, N.D., Messah, G.E., Kimzey, S.L., Shaw, A.S.,the following protease and phosphatase inhibitors: NaF (10 mM),
Arch, R.H., and Green, J.M. (2001). Cutting edge: distinct motifs-glycerophosphate (10 g/ml), Na3VO4 (150 M), PMSF (1 mM),
within CD28 regulate T cell proliferation and induction of bcl-x(l). J.leupeptin (1 g/ml), chymostatin (1 g/ml), pepstatin A (1 g/ml),
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